Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's disease.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002766:Cholecystokinin / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D004347:Drug Interactions; D005116:Extrapyramidal Tracts / Q000378:metabolism; D006220:Haloperidol / Q000008:administration & dosage; D008297:Male; D008781:Methyltyrosines / Q000008:administration & dosage; D010300:Parkinson Disease / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012110:Reserpine / Q000008:administration & dosage; D019805:alpha-Methyltyrosine
D008781:Methyltyrosines; D019805:alpha-Methyltyrosine; D012110:Reserpine; D002766:Cholecystokinin; D006220:Haloperidol; D004298:Dopamine